Deals
KKR Nears Deal for Cotiviti Valuing Firm at $11 Billion
- Wall Street banks, private lenders are vying for financing
- PE firms in talks to borrow $5 billion to $6 billion for deal
This article is for subscribers only.
Private equity firm KKR & Co. is said to be nearing a deal to buy a stake in Cotiviti Inc. from Veritas Capital, reviving a battle between Wall Street banks and private credit lenders to provide financing for one of the year’s biggest buyouts.
KKR is in discussions to buy a 50% stake in Cotiviti that would value the health-care technology company at between $10 billion and $11 billion, according to people with knowledge of the matter.